Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Rocket Pharmaceuticals Q2 EPS $(0.83) Down From $(0.55) YoY

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.83) per share. This is a 50.91 percent decrease over losses of $(0.55) per share from the same period last year.
byMichael Horton
August 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.83) per share. This is a 50.91 percent decrease over losses of $(0.55) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts